Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on: December 28,2023

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on:December 28,2023

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on: March 20,2024

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on:March 20,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on: July 04,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on:July 04,2024

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on: April 02,2024

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on:April 02,2024

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on: January 02,2024

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on:January 02,2024

Discovery points to new approach to treating liver cancer

by Mary Martialay,Purdue UniversityReduced DDX5 protein levels in human HCCs associated with increased tumor grade and poor patient survival following sorafenib treatment.AImmunohist

Updated on: January 24,2024

Discovery points to new approach to treating liver cancer

by Mary Martialay,Purdue UniversityReduced DDX5 protein levels in human HCCs associated with increased tumor grade and poor patient survival following sorafenib treatment.AImmunohist

Updated on:January 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on: March 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on:March 24,2024

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on: February 01,2024

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on:February 01,2024

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

by Jennifer Brown,University of IowaCredit: CC0 Public DomainAn on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder

Updated on: January 07,2024

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

by Jennifer Brown,University of IowaCredit: CC0 Public DomainAn on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder

Updated on:January 07,2024

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr

Updated on: March 13,2024

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr

Updated on:March 13,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on: February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on:February 19,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on: January 23,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on:January 23,2024